The five-year Regional Victorian Trials Alliance, Linkages, Special populations, Equity (ReViTALISE) Program is a collaborative initiative offering critical, cancer-related clinical trials and research to regional Victoria.
The Palliative Nexus group leads the Regional Palliative and Supportive Care Research stream of the program, providing palliative care patients at eight regional sites with access to clinical trials, including the use of registry and telehealth trials.
The ReViTALISE Program was awarded $18.6 million from the Australian Government Medical Research Future Fund (MRFF) in October 2020. It hopes to address equity of access for a group of people who may have difficulty travelling, yet still wish to participate in trials of emerging research practices.